Cargando…
Primary peritoneal myeloid sarcoma in association with CBFB/MYH11 fusion
Myeloid sarcoma, also known as chloroma or granulocytic sarcoma is an extramedullary disease process that typically presents in association with acute myeloid leukemia during initial presentation or at relapse. Often associated with cytogenetic mutations, including t(8;21)(q22;q22); RUNX1/RUNX1T1, a...
Autores principales: | Kuhlman, Justin J., Abdel Rahman, Zaid H., Jiang, Liuyan, Menke, David M., Foran, James M., Murthy, Hemant S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008180/ https://www.ncbi.nlm.nih.gov/pubmed/33816105 http://dx.doi.org/10.1016/j.lrr.2021.100238 |
Ejemplares similares
-
CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes
por: Huang, Benjamin J., et al.
Publicado: (2021) -
Comprehensive Mutation Profile in Acute Myeloid Leukemia Patients with RUNX1-RUNX1T1 or CBFB-MYH11 Fusions
por: Qin, Wei, et al.
Publicado: (2022) -
Molecular dissection of a hyper-aggressive CBFB-MYH11/FLT3-ITD–positive acute myeloid leukemia
por: Lo Iudice, Gabriele, et al.
Publicado: (2022) -
Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knockin mice
por: Hyde, R. Katherine, et al.
Publicado: (2015) -
How to Improve Prognostication in Acute Myeloid Leukemia with CBFB-MYH11 Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) Monitoring
por: Talami, Annalisa, et al.
Publicado: (2021)